Pay in 4 interest-free payments of $24.75 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
DeLucas LJ
Dominguez E
Smiles: C(NC1N=CC=CN=1)C1C=CC(CNC2N=CC=CN=2)=CC=1
Epub 2017 Apr 24
THZ1 - Covalent CDK7 Inhibitor. CAS# 1604810-83-4 284 DeLucas LJTHZ1, CAS No. 1604810 83 4, is a novel potent, selective and cell permeable irreversible CDK7 inhibitor with an IC50 ~3. 2 nM. THZ1 has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. Cancer cell line profiling indicates that a subset of cancer cell lines, including human T cell acute lymphoblastic leukaemia (T ALL), have
US$ 23.00
US$ 139.95
US$ 129.95